No Ifs, Ands Or Butts – Preemption Gutts, Rebutts, And Shutts Down ... - Mondaq News Alerts (registration)

No Ifs, Ands Or Butts – Preemption Gutts, Rebutts, And Shutts Down ...
Mondaq News Alerts (registration)
Late last year we happily blogged about Utts v. Bristol-Myers Squibb Co., ___ F. Supp.3d ___, 2016 WL 7429449 (S.D.N.Y. Dec. 23, 2016), chiefly because it held that design defect claims against a branded prescription drug (Eliquis) were preempted under ...